Co-Author
This page shows the publications co-authored by Dan Barouch and Lisa Tostanoski.
Connection Strength
9.279
-
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters. NPJ Vaccines. 2022 Jan 10; 7(1):2.
Score: 0.980
-
Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern. Sci Transl Med. 2021 Nov 03; 13(618):eabj3789.
Score: 0.968
-
Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2. J Virol. 2021 11 09; 95(23):e0097421.
Score: 0.959
-
Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2. bioRxiv. 2021 Jun 15.
Score: 0.942
-
Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nat Med. 2020 11; 26(11):1694-1700.
Score: 0.893
-
Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters. Med (N Y). 2022 Apr 08; 3(4):262-268.e4.
Score: 0.248
-
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques. Sci Adv. 2022 Mar 18; 8(11):eabl6015.
Score: 0.248
-
Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice. NPJ Vaccines. 2022 Feb 23; 7(1):23.
Score: 0.247
-
Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants. Sci Transl Med. 2021 Nov 03; 13(618):eabj2641.
Score: 0.242
-
A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates. bioRxiv. 2021 Jul 14.
Score: 0.237
-
Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera. J Virol. 2021 06 24; 95(14):e0040421.
Score: 0.236
-
Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques. Nature. 2021 08; 596(7872):423-427.
Score: 0.236
-
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women. JAMA. 2021 06 15; 325(23):2370-2380.
Score: 0.236
-
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. Nature. 2021 08; 596(7871):268-272.
Score: 0.235
-
Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques. Cell. 2021 06 24; 184(13):3467-3473.e11.
Score: 0.235
-
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021 04 20; 325(15):1535-1544.
Score: 0.233
-
Novel approaches for vaccine development. Cell. 2021 03 18; 184(6):1589-1603.
Score: 0.232
-
Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2021 Feb; 590(7844):E25.
Score: 0.230
-
Low-Dose Ad26.COV2.S Protection Against SARS-CoV-2 Challenge in Rhesus Macaques. bioRxiv. 2021 Jan 27.
Score: 0.229
-
Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. 2021 02; 590(7847):630-634.
Score: 0.227
-
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2020 10; 586(7830):583-588.
Score: 0.222
-
DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science. 2020 08 14; 369(6505):806-811.
Score: 0.219
-
SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020 08 14; 369(6505):812-817.
Score: 0.219
-
Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection against Zika Virus Challenge in Pregnant IFN-aßR-/- Mice. Cell Host Microbe. 2019 11 13; 26(5):591-600.e4.
Score: 0.210
-
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice. Proc Natl Acad Sci U S A. 2021 09 21; 118(38).
Score: 0.060
-
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters. bioRxiv. 2021 Mar 04.
Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.